Trade Moderna Inc ^MRNA

Biotech Stocks To Keep An Eye On - October 6th - Markets Daily

AI Breakthrough: Room Temperature Storage for mRNA Vaccines, ETPharma

U.S. Market Brief: Wall Street Ends Lower as Fed Minutes Reinforce Rate Rise Outlook

U.S. Market Brief: Stocks Slip as Fed Minutes Signal Another Rate Hike

Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets

Odd Biotech Action Is Creating Opportunities for Deal Hunters

Morgan Stanley Issues Positive Forecast for Moderna (NASDAQ:MRNA) Stock Price

Moderna (NASDAQ:MRNA) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Stock Observer

Top Healthcare Stocks To Watch Now - October 7th - Daily Political

Moderna (MRNA) Could Be 57% Above Fair Value On New COO Appointment

Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?

Moderna (NASDAQ:MRNA) Hits New 52-Week High - Time to Buy?

Paramount-Warner Bros. deal finally closes: Stocks to watch on Tuesday

Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher

Promising Healthcare Stocks To Watch Now - October 6th - Stock Observer

NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'

NVAX Stock Outruns Moderna As Vaxcyte's Shot Clears A Late-Stage Test

MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns

Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up

Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips

Value Stocks To Consider - October 5th - Stock Observer

ETFs Are Net Sellers of Moderna (MRNA) on Thursday

Hawaii pharmacies offering COVID vaccines amid uptick

Moderna (MRNA) Soars 175% in Q3: Can The Stock Keep Running?

Jim Cramer Says This Stock Could Rise Like Moderna (MRNA)

Biotech Stocks To Watch Now - October 2nd - Daily Political

Why Is Moderna (MRNA) Bringing Back A Manufacturing Leader As First COO?

Biotech Stocks To Watch Now - October 2nd - Zolmax

S&P500: Futures Rise as Oil Retreats Before Payrolls | FXEmpire

Moderna (MRNA) Jumps 2.2% in Premarket as Nasdaq-100 Entry Confirmed for October 9

Moderna To Join Nasdaq-100, Replacing Warner Bros. Discovery

Micron Says Memory Supply Will Be Much Tighter in 2028. Sandisk's Contracts Limit How Much It Can Gain.

Northwestern Wins Bid to Strike Moderna Government Sales Defense

September's Leaders and Laggards

Moderna loses US government license defense in patent case

Why Citi Is Sounding the Alarm on Moderna Stock

Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water

Biotech Stocks To Watch Now - October 1st - Daily Political

Lyme Disease Market: Steady Growth Ahead as Vaccine Candidates and Novel Preventive Therapies Advance Through 2034 | ABNewswire

This Analyst Just Downgraded Moderna Stock. Here's Why.

Moderna Stock Slumps as Citi Says It's Time to Sell After 500% Rally This Year

Moderna Stock Falls 7% After Adding Chief Operating Officer Role

Moderna (NASDAQ:MRNA) Shares Gap Down - Here's Why

Moderna Names Juan Andres As Chief Operating Officer

Case: Patents/Eligibility (D. Del.)

Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat

Target upgraded, Moderna downgraded: Wall Street's top analyst calls

Citi Downgrades Moderna (MRNA) Stock to Sell After 222% Rally

Here Are Wednesday's Top Wall Street Analyst Research Calls: Ally Financial, BankUnited, Ciena Corporation, CoreWeave, Dow, FormFactor, Lumentum Holdings, Moderna, Target, and More

Premarket movers: Micron; Boeing rises, Moderna slides

Moderna (NASDAQ:MRNA) Shares Gap Down - Should You Sell? - Stock Observer

Citi tells investors it's time to sell Moderna after 600%-plus stock gains | Morningstar

MRNA: Cancer Vaccine Wins Matter, But The Case Now Rests On Narrower Proof Points

Moderna has been on a tear since mid-August. Citi now sees it plunging 60%

Bayer Advances Patent Suit Over Moderna, Pfizer Covid Vaccines

Moderna (NASDAQ:MRNA) Sets New 12-Month High - Here's What Happened

Promising Healthcare Stocks To Follow Today - September 29th - Stock Observer

Healthcare Stocks To Add to Your Watchlist - September 28th - Zolmax

MIT engineers use artificial intelligence to create heat-resistant RNA vaccines

Top Biotech Stocks To Research - September 28th - Daily Political

Why Did AMD, HPE, MRNA Stocks Surge To 52-Week Highs Last Week?

Biotech Stocks To Follow Today - September 27th - Daily Political

Moderna (MRNA) Held Investment Talks With The UAE Government

Top Biotech Stocks To Add to Your Watchlist - September 26th - Zolmax

Weekly Market Update: Stocks Gain 1.09% as Technology Rises, Energy Falls | Morningstar

Stock Traders Purchase Large Volume of Call Options on Moderna (NASDAQ:MRNA)

Moderna (MRNA) Stock Looks Overvalued Against Its Current Sales Base

Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of "Hold" from Analysts

Moderna Inc. (MRNA) Holds High-Level Investment Talks With UAE, Soars to 4-Year Peak

Healthcare Stocks To Watch Today - September 24th - Zolmax

Bucks Music Group Signs Pianist And Composer Piotr Wiese

Moderna (MRNA) Stock Reaches New 52-Week Peak Amid Cancer Treatment Breakthroughs

Biotech Stocks At 52-Week Highs - TKNO, MRNA, ATRC, ILMN

Nykredit A S Acquires New Holdings in Moderna, Inc. $MRNA

Engineers Gate Manager LP Cuts Holdings in Moderna, Inc. $MRNA

Healthcare Stocks Fall - Healthcare Roundup | Morningstar

Moderna Eyes Cancer Vaccine Filing as It Expands Beyond COVID

Healthcare Stocks To Add to Your Watchlist - September 23rd - Stock Observer

Biotech Stocks To Follow Now - September 23rd - Stock Observer

Moderna (MRNA) Tied To AI Drug Push As Bob Langer Takes New Advisory Role

Moderna (MRNA) Stock Looks Very Expensive As Shares Surge Over 1 Year

Moderna (NASDAQ:MRNA) Trading Up 5.6% - What's Next?

Top Value Stocks To Watch Today - September 22nd - Zolmax

Moderna (NASDAQ:MRNA) Trading 5.6% Higher - Time to Buy? - Daily Political

Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up?

mRNA flu vaccine wins FDA approval, promising a faster shot

How the Merck-Moderna mRNA melanoma vaccine is built per patient

Top Healthcare Stocks To Keep An Eye On - September 22nd - Stock Observer

Biotech Stocks To Consider - September 19th - Zolmax

MRNA: Melanoma Success Lifts The Story, The Stock Still Prices In Too Much

Moderna (NASDAQ:MRNA) Trading Up 12.3% - Still a Buy?

Health Care Up on Drug Breakthrough Hopes - Health Care Roundup | Morningstar

AMD, Intel, Meta, Warner Bros., Moderna, Grail, Strategy, and More Stocks That Explain Today's Market

Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters. | Morningstar